However, both tests are semi-quantitative and require sophisticated laboratory techniques and instrumentation, therefore, it is desirable to develop simpler, sensitive, rapid, and scaleable genetic detection methods to check the HER2 status of breast cancer patients [8], [9]. The gene discussed is ERBB2; the disease is breast cancer.